Efficacy of urine sodium content measurement at 1 h after intravenous furosemide administration in patients with acute decompensated heart failure

Efficacy of urine sodium content measurement at 1 h after intravenous furosemide administration in patients with acute decompensated heart failure - Efficacy of urine sodium content measurement at 1 h after intravenous furosemide administration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047161

Enrollment

360

Registered

2022-03-15

Start date

2022-03-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients required intravenous furosemide administration due to symptoms or signs due to fluid retention 2. Patients required hospital admission

Exclusion criteria

Exclusion criteria: 1. Patients underwent hemodialysis or anuria 2. Patients who are considered not suitable for inclusion of this study

Design outcomes

Primary

Measure	Time frame
Change of congestion score	—

Secondary

Measure	Time frame
All-cause mortality (1-year) Rehospitalization due to heart failure (during 1-year) Change in body weight during initial hospitalization	—

Countries

Japan

Contacts

Public ContactMitsutoshi Oguri

Kasugai Municipal Hospital Department of Cardiology

oguricap0909@gmail.com0568-57-0057

Outcome results